Dr Cathy D Chong, MD, MPH | |
825 Main St, Weymouth, MA 02190-1659 | |
(781) 337-3424 | |
(781) 337-7569 |
Full Name | Dr Cathy D Chong |
---|---|
Gender | Female |
Speciality | Otolaryngology |
Experience | 30 Years |
Location | 825 Main St, Weymouth, Massachusetts |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043205974 | NPI | - | NPPES |
3195686 | Medicaid | MA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 159675 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
South Shore Hospital | South weymouth, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Massachusetts Eye And Ear Associates, Inc | 4486540275 | 337 |
News Archive
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which is published online ahead of print in JAMA Internal Medicine.
Neovasc Inc., today announced that it has received Canadian Food Inspection Agency (CFIA) approval to export its processed pericardial tissue products to Europe as an "intermediate product" under the requirements of Annex I of EC Regulation # 2007/2006. This approval allows European customers to import Neovasc's porcine and bovine pericardial tissue materials for use in the manufacture of their own medical devices.
A study from The Scripps Research Institute has unveiled a surprising mechanism that controls brain formation. The findings have implications for understanding a host of diseases, including some forms of mental retardation, epilepsy, schizophrenia, and autism.
Adding the targeted therapy ribociclib to hormone therapy significantly improved overall survival (OS) in premenopausal patients with advanced hormone receptor-positive (HR+) breast cancer, according to results of the MONALEESA-7 Phase III clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.
› Verified 3 days ago
Entity Name | Massachusetts Eye And Ear Associates, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1932574332 PECOS PAC ID: 4486540275 Enrollment ID: O20040227000123 |
News Archive
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which is published online ahead of print in JAMA Internal Medicine.
Neovasc Inc., today announced that it has received Canadian Food Inspection Agency (CFIA) approval to export its processed pericardial tissue products to Europe as an "intermediate product" under the requirements of Annex I of EC Regulation # 2007/2006. This approval allows European customers to import Neovasc's porcine and bovine pericardial tissue materials for use in the manufacture of their own medical devices.
A study from The Scripps Research Institute has unveiled a surprising mechanism that controls brain formation. The findings have implications for understanding a host of diseases, including some forms of mental retardation, epilepsy, schizophrenia, and autism.
Adding the targeted therapy ribociclib to hormone therapy significantly improved overall survival (OS) in premenopausal patients with advanced hormone receptor-positive (HR+) breast cancer, according to results of the MONALEESA-7 Phase III clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Cathy D Chong, MD, MPH 825 Main St, Weymouth, MA 02190-1659 Ph: (781) 337-3424 | Dr Cathy D Chong, MD, MPH 825 Main St, Weymouth, MA 02190-1659 Ph: (781) 337-3424 |
News Archive
A new, team-based, primary care model is decreasing prescription opioid use among patients with chronic pain by 40 percent, according to a new study out of Boston Medical Center's Grayken Center for Addiction Medicine, which is published online ahead of print in JAMA Internal Medicine.
Neovasc Inc., today announced that it has received Canadian Food Inspection Agency (CFIA) approval to export its processed pericardial tissue products to Europe as an "intermediate product" under the requirements of Annex I of EC Regulation # 2007/2006. This approval allows European customers to import Neovasc's porcine and bovine pericardial tissue materials for use in the manufacture of their own medical devices.
A study from The Scripps Research Institute has unveiled a surprising mechanism that controls brain formation. The findings have implications for understanding a host of diseases, including some forms of mental retardation, epilepsy, schizophrenia, and autism.
Adding the targeted therapy ribociclib to hormone therapy significantly improved overall survival (OS) in premenopausal patients with advanced hormone receptor-positive (HR+) breast cancer, according to results of the MONALEESA-7 Phase III clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.
› Verified 3 days ago
Amee K Dharia, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 825 Main St, Weymouth, MA 02190 Phone: 781-337-3424 Fax: 781-340-3782 | |
Hani Ibrahim, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 825 Main St, Weymouth, MA 02190 Phone: 781-337-3424 Fax: 781-337-7569 | |
Robin Brittany Pappal, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 825 Main St, Weymouth, MA 02190 Phone: 781-337-3424 | |
Richard S Hill, M.D. Otolaryngology Medicare: May Accept Medicare Assignments Practice Location: 825 Main St, Weymouth, MA 02190 Phone: 781-803-6380 Fax: 781-803-6379 | |
Bridget Driscoll Burgess, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 825 Main St Fl 1, Weymouth, MA 02190 Phone: 781-337-3424 |